Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z003310 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No additional AE; HCP calling to report TE PROQUAD administered on 08/13/2025; This spontaneous report was received from an other health professional and refers to an patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 13-AUG-2025, the patient was vaccinated with an improperly storage of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (dose, route of administration and anatomical location were not reported, lot number Z003310, which was verified to be valid, and expiration date on 21-JUL-2026), the vaccine was reconstituted with sterile diluent (Hollister Sterile Diluent), for prophylaxis. The administered dose of the vaccine experienced a temperature excursion -11.7 degrees Celsius for 31 minutes, it was not reported if the information was recorded by a data logger or not. There was no adverse effect reported.